OARSI Weekly Briefing - May 20, 2022

World Congress Attendees: Recorded Sessions 

Thank you for joining us for the 2022 Hybrid World Congress on Osteoarthritis! Whether you attended in-person or joined from the virtual stage, OARSI on-demand is ready for you. All plenary and concurrent sessions recorded onsite in Berlin, Germany are available within OARSI's virtual meeting platform.*: 

For virtual platform login help, please click here. 

*Please note: Only users who have registered for the congress will be able to view these sessions. Pre-congress workshops, the clinician trails symposium, breakfast workshops, discussion groups, and social events are not included in the on-demand library.

Did You Miss This Week's OARSI Live Webinar?

The OARSI Live webinar on May 18 featured three of the highest ranking abstracts in the field of Omics from the 2022 Hybrid World Congress on Osteoarthritis:

Moderator: Gun-il Im, MD, PhD, Dongguk University, Republic of Korea

Presenters: Cecile Henkel, MD, PhD candidate, Copenhagen University Hospital, Denmark

Ana Luiza de S.V. Arruda, PhD candidate, Germany

Michael Jurynec, PhD, University of Utah, United States

OARSI Live webinar recordings are available to members for free as a membership benefit. If you missed any of our recent webinars, you may view them on the OARSI Live Webinar Recordings  page. Be sure to have your OARSI username and password handy to access this member-protected page.

Member Spotlight: Magali Cucchiarini

This week's member spotlight is OARSI Board of Director Member, Magali Cucchiarini.

How long have you been a member of OARSI and why did you join?
I have been a member for over 18 years. I joined OARSI because it is the premier international organization for scientists and health care professionals focusing on the understanding, prevention, and treatment of OA.

What do you enjoy most about OARSI?
OARSI connects worldwide experts working in OA and supports excellent and interactive research at top-level, in a very professional and friendly manner. OARSI also promotes strong collaborations between groups. Through OARSI, I had the great opportunity to develop as a scientist thanks to many collaborators that became mentors and friends.

Tell us a little bit about your research?
Our work focuses on developing novel, effective gene-, cell-, and tissue engineering-based options to treat human OA. A particular focus of our Institute is the manipulation of clinically adapted rAAV gene therapy vectors and their application in vivo in a controlled release fashion using biocompatible materials and scaffolds such as hydrogels, as improved drug delivery systems to manage OA in individuals.

What are you most excited about for the future of OARSI?
OARSI has always been very dedicated to connecting people coming from different horizons, all converging towards one goal - understanding OA to definitely cure it - with a deep interest in promoting and supporting the future generations of researchers and clinicians via measures of diversity, equity, and inclusion. It gives a lot of hope that OARSI will reach this common goal, eventually.

What do you enjoy doing in your free time?
Yoga, reading (I always go back to my roots: Camus, Descartes), and caring for my garden (it helps me meditate on life and work).

To learn more about Dr. Cucchiarini, visit this link. 

Thank You to Our 2022 Sponsors & Exhibitors 

Thank You to Our 2022 Industry Partners

Important Dates & Upcoming Deadlines

• March 17-20, 2023 - 2023 OARSI World Congress on Osteoarthritis, Denver, Colorado

FOLLOW OARSI
    
<<UNSUBSCRIBE_LINK_HTML>>
© 2022 Osteoarthritis Research Society International.
All Rights Reserved. 1120 Rt. 73, Suite 200 | Mt. Laurel, NJ 08054